Anticancer Drug Development, System Updating and Global Participations

Title:Anticancer Drug Development, System Updating and Global Participations

Volume: 12 Issue: 1

Author(s): Da-Yong Lu*, Ting-Ren Lu, En-Hong Chen, Nagendra Sastry Yarla, Bin Xu, Jian Ding and Hong Zhu

Affiliation:

• School of Life Sciences, Shanghai University, Shanghai 200444,China

Keywords: Anticancer drug development, neoplasm metastasis, cost-effective, medicinal chemistry, animal models, drug toxicity, cancer stem cells, individualized cancer therapy.

Abstract: Background: New anticancer drug discovery, development and manufacture entered the bottleneck stage. Many limitations of both technology and animal models slow down the anticancer drug developments

Objective: To ease economic burdens for drug developers and general patient populations.

Methods: Key factors affecting anticancer drug developments and possible roadmaps for updating drug screening routines worldwide are suggested.

Results: Drug development chains must be updated and better drug development paradigms must be established.

Conclusions: This world welcomes global participations in anticancer drug developments and utilities.

Cite this article as:

Lu Da-Yong*, Lu Ting-Ren, Chen En-Hong, Yarla Sastry Nagendra, Xu Bin, Ding Jian and Zhu Hong, Anticancer Drug Development, System Updating and Global Participations, Current Drug Therapy 2017; 12 (1) . https://dx.doi.org/10.2174/1574885511666161025122906

DOI https://dx.doi.org/10.2174/1574885511666161025122906	Print ISSN 1574-8855
Publisher Name Bentham Science Publisher	Online ISSN 2212-3903